CONCLUSIONS
OST pulmonary metastases
ONCOLOGY, PULMONARY METASTASES
Our patients with OST pulmonary metastases have comparable poor survival outcomes despite varying surgical approaches to PM. While our study reinforces the clinical equipoise between thoracotomy and thoracoscopy, we could not assess for surgical bias and other competing risks given the limitations of a retrospective study. This will be addressed in the ongoing Children's Oncology Group trial AOST2031 (NCT05235165), a prospective randomized clinical trial evaluating outcomes between thoracotomy and thoracoscopy in the management of pulmonary metastases for OST.